LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the highest dose level studied to date in patients with refractory metastatic colorectal cancer enrolled in an ongoing U.S. Phase 1 clinical trialLYL273 is a GCC-targeted CAR T-cell product candidate armed with enhancements designed to improve CAR T-cell expansion and cancer...

Acquisition of $15M stone distributor on track to close before December 15; the multi-location business will add revenue, EBITDA, and scale in a fast-growing category. NEW YORK CITY, NEW YORK / ACCESS Newswire ( ACCS ) / November 10, 2025 / Capstone Holding Corp. ( CAPS ) , a national building products distribution platform, today announced that it expects to...

Transaction Appears Designed to Enable Tiptree Management to Extract Value from Shareholders While Running a Blank Check Company Intends to Vote AGAINST the Unfair Transaction, Which Is Structured to Benefit Tiptree Management at the Expense of Tiptree Shareholders Urges the Tiptree Board of Directors to Restructure the Transaction and Deliver the $28.75 per Share Consideration Directly to Tiptree Shareholders,...

Strategic combination positions combined company to capture AI infrastructure demand at scale Movano shareholders gain exposure to rapidly emerging AI infrastructure pure play platform with differentiated product offering, a growing sales pipeline with attractive credit quality, leadership experienced in large-scale distributed computing and software development, and disciplined capital allocation Merger exchange ratio based upon a Movano per share value...